Treatment of orbital haemangiopericytoma with surgery and preoperative embolization by Jeeva, Irfan et al.
eCommons@AKU
Section of Ophthalmology Department of Surgery
January 2013
Treatment of orbital haemangiopericytoma with
surgery and preoperative embolization
Irfan Jeeva
Aga Khan University, irfan.jeeva@aku.edu
B Y P Chang
Leeds Teaching Hospitals, Leeds, UK
L Bagdonaite
Leeds Teaching Hospitals, Leeds, UK
G Kalantzis Kalantzis
Leeds Teaching Hospitals, Leeds, UK
T E Fearnley Fearnley
Leeds Teaching Hospitals, Leeds, UK
See next page for additional authors
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_surg_ophthalmol
Part of the Ophthalmology Commons
Recommended Citation
Jeeva, I., Chang, B., Bagdonaite, L., Kalantzis, G., Fearnley, T., Ismail, A., Patankar, T., Goddard, T. (2013). Treatment of orbital
haemangiopericytoma with surgery and preoperative embolization. Eye, 27(2), 283-284.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_ophthalmol/17
Authors
Irfan Jeeva, B Y P Chang, L Bagdonaite, G Kalantzis Kalantzis, T E Fearnley Fearnley, A Ismail, T Patankar
Patankar, and T Goddard
This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_surg_ophthalmol/17
2 de Klerk TA, Moriarty AP. Comment on ‘Deep sclerectomy
with mitomycin C in eyes with failed glaucoma surgery and
pseudophakia’. Eye 2012; 27(2): 281–282.
3 Anand N, Wechsler D. Deep sclerectomy with mitomycin C
in eyes with failed glaucoma surgery and pseudophakia.
Eye 2012; 26: 70–79.
4 Garudadri CS, Rao HL, Senthil S. Three-year follow-up of
the tube versus trabeculectomy study. Am J Ophthalmol 2010;
149: 685–686.
5 WuDunn D, Cantor LB, Palanca-Capistrano AM, Hoop J,
Alvi NP, Finley C et al. A prospective randomized trial
comparing intraoperative 5-fluorouracil vs mitomycin C in
primary trabeculectomy. Am J Ophthalmol 2002; 134: 521–528.
N Anand1 and D Wechsler2
1Department Of Ophthalmology, Calderdale &
Huddersfield NHS Trust, Huddersfield Royal Infirmary,
Huddersfield, UK
2Burwood Eye Clinic, Burwood, New South Wales,
Australia
E-mail: anand1604@gmail.com
Eye (2013) 27, 282–283; doi:10.1038/eye.2012.246;
published online 7 December 2012
Sir,
Treatment of orbital haemangiopericytoma with
surgery and preoperative embolization
We describe a case of extraconal orbital
haemangiopericytoma that was completely resected
following particle embolisation of the feeding artery.
Case report
A 22-year-old female patient presented with a 10-month
history of progressive ptosis, generalised
ophthalmoplegia, hypoglobus, and 6/6 visual acuity
(VA). MRI with contrast of the orbits revealed a well-
defined extraconal lesion above the superior rectus with
homogenous enhancement and multiple flow voids,
suggesting a vascular tumour. Cerebral angiography
demonstrated dense tumour staining, showing multiple
feeders to the tumour distal to origin of central retinal
artery (CRA). The ophthalmic artery was catheterised
using Marathon Flow Directed Micro Catheter (EV3;
Irvine, CA, USA) and a Mirage 0.008 Guidewire (EV3),
and safely placed distal to CRA (Figure 1a). Embosphere
particles measuring 150–300 mm were injected slowly
through distal ophthalmic artery into the tumour, under
constant blank roadmap, to prevent particles floating
retrogradely into the CRA. Approximately 95%
devascularisation of the tumour was achieved with a
small remnant feeder close to CRA (Figure 1b). Complete
excision via lid crease approach was performed
subsequently (Figures 2a and b).
Figure 1 (a, b) Pre- and post-embolisation of the lesion.




Histopathology revealed thin collagenous capsule
surrounding sheets of high density of oval cells with little
pleomorphism and moderate mitotic activity. Necrosis
was no seen. Tumour cells surrounded branching
capillaries, giving staghorn appearance.
Immunohistochemical stains of tumour cells were
positive for CD34, CD99, Bcl-2, and Vimentin and
negative for EMA, S-100, and SMA. The proliferative
index (Ki-67) was positive in 5% of the tumour cells.
These characteristic signs confirmed diagnosis of
haemangiopericytoma.
Patient maintained 6/5 VA 1-year following surgery.
Comment
Haemangiopericytoma of the orbit is a rare, slow
growing vascular tumour. Its incidence is 0.3–3% of all
orbital biopsies.1,2 Incomplete resection is associated with
a high rate of recurrence and malignant conversion.2
Complete removal of the lesion is considered the
mainstay treatment.3
Gear et al4 recommend radiotherapy for recurrent
superficial tumour, however, radiotherapy carries the
risk of ischaemic optic neuropathy, as does embolization.
Takahashi et al5 described excision of the lesion following
embolization by polyvinyl alcohol to reduce tumour size.
To the best of our knowledge, this is the first reported
case of haemangiopericytoma treated with particle
embolization followed by en bloc excision of the lesion.
Pre-excision embolization shrinks tumour, reducing the
risk of intraoperative haemorrhage. We recommend
preoperative embolization a useful technique for
haemangiopericytoma treatment.
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